Hypothyroidism in patients with multiple myeloma following treatment with thalidomide

被引：52

作者：

Badros, AZ

Siegel, E

Bodenner, D

Zangari, M

Zeldis, J

Barlogie, B

Tricot, G

机构：

[1] Univ Arkansas Med Sci, Myeloma & Transplantat Res Ctr, Little Rock, AR 72205 USA

[2] Univ Arkansas Med Sci, Dept Endocrinol, Little Rock, AR 72205 USA

[3] Celgene Corp, Warren, NJ USA

来源：

关键词：

D O I：

10.1016/S0002-9343(01)01137-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：412 / 413

页数：2

共 16 条

[1] ALEXANDER IRW, 1961, BRIT MED J, V2, P1434, DOI 10.1136/bmj.2.5264.1434-a
[2] Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients
Barlogie, B
Desikan, R
Eddlemon, P
Spencer, T
Zeldis, J
Munshi, N
Badros, A
Zangari, M
Anaissie, E
Epstein, J
Shaughnessy, J
Ayers, D
Spoon, D
Tricot, G
[J]. BLOOD, 2001, 98 (02) : 492 - 494
[3] Bladé J, 2000, ACTA ONCOL, V39, P843
[4] Interpretation of thyroid function tests
Dayan, CM
[J]. LANCET, 2001, 357 (9256) : 619 - 624
[5] The pattern of a TH1 cytokine in autoimmune thyroiditis
Drugarin, D
Negru, S
Koreck, A
Zosin, I
Cristea, C
[J]. IMMUNOLOGY LETTERS, 2000, 71 (02) : 73 - 77
[6] ESSER H, 1956, Ther Ggw, V95, P374
[7] LILLICRAP DA, 1962, BMJ-BRIT MED J, V1, P477
[8] MANTEL N, 1959, J NATL CANCER I, V22, P719
[9] ANTITHYROID ACTIVITY OF N-PHTHALYL GLUTAMIC ACID IMIDE (K17)
MURDOCH, JM
CAMPBELL, GD
[J]. BRITISH MEDICAL JOURNAL, 1958, 1 (JAN11) : 84 - 85
[10] Serum levels of the cytokines IL-1β, IL-6 and ICAM-1 after 131I-treatment of Graves' disease and nodular goiter
Nygaard, B
Jarlov, AE
Kristensen, LO
Faber, J
[J]. HORMONE AND METABOLIC RESEARCH, 2000, 32 (07) : 283 - 287